Stock screenerAll disclosures →
EDGAR →
IMVT
Conviction 82HealthcareScan · Thu, Jun 25, 2026IMVT$38.24+0.04%
ResistanceSupportVol 14Insider sell2
4
2
4
Vol MA14 1.61M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price38.24
Change+0.04%
Gap+0.99%
Rel volume1.12×
Avg volume1.66M
Avg $ vol56.46M
SMA 2033.74
SMA 5030.95
SMA 20025.16
Price vs 50+23.55%
Price vs 200+51.99%
MA stackbullish
50/200 cross—
Supertrendup · 33.68
RSI (14)71
MACD hist0.48
MACD crossbull · 5d
Stoch %K / %D89 / 89
ADX (14)33
+DI / −DI38 / 10
RSI divergence—
MACD divergence—
ATR %+4.33%
ADR %4.49%
52w high38.24
52w low14.69
From 52w high+0.00%
Above 52w low+160.28%
New 52w highYes
SqueezeOff
Bollinger width29.30%
%B0.95
Donchian pos88.93%
Donchian high39.23
Donchian low30.24
AVWAP (52w high)38.47
vs AVWAP high-0.60%
AVWAP (52w low)24.79
vs AVWAP low+54.26%
OBV trendUp
Chaikin MF (20)0.18
Today vs 20d1.12×
Avg vol (14d)1.61M
Avg vol (20d)1.66M
Avg $ vol (20d)56.46M
Market cap7.85B
RS 3m (vs SPY)+48.06%
RS 6m (vs SPY)+35.52%
RS line new highYes
Trend template8/8
Technical rank91.1
1 week+10.16%
1 month+13.02%
3 months+54.42%
6 months+38.83%
1 year+138.97%
YTD+47.57%
P/E-15.53
P/B9.21
P/S—
P/FCF-19.27
EPS-2.77
Div yield—
ROE-59.30%
ROA-52.83%
Debt/Eq—
Current9.09
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-22.17%
Price target46.33
Target upside21.17%
Analyst ratingBuy
Institutional58.15%
Ent. value6.95B
Revenue—
Net income-110.64M
Gross profit—
Free cash flow-407.32M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out205.31M
Employees315
ListedFri, Jun 21, 2019
Free float79.09M
Float %38.9%
Short interest19.21M
Days to cover5.0d
Short volume61.1%
Squeeze score81 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.73 vs −$0.60
Last surprise-21.7% miss
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank91.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance34.59
Support26.26
Days since event—
Candle confirm—
News sentiment—
Financials as of Wed, Dec 31, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in IMVT
No recent disclosed trades by Congress in IMVT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IMVT · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Van Tuyl Christopher Chief Legal Officer · Common Stock · 2026-06-18 | Sell | 2.63K | $93K | 2026-06-18 | 2026-06-22 |
Fromkin Andrew J. Director · Common Stock · 2026-05-28 | Sell | 210.47K | $7.1M | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Stock Option (right to buy) · 2026-05-28 | Exercise | 31.67K | $0 | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Common Stock · 2026-05-28 | Exercise | 16.26K | $239K | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Common Stock · 2026-05-28 | Exercise | 31.67K | $158K | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Common Stock · 2026-05-28 | Exercise | 77.18K | $651K | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Stock Option (right to buy) · 2026-05-28 | Exercise | 16.26K | $0 | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Stock Option (right to buy) · 2026-05-28 | Exercise | 71.49K | $0 | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Common Stock · 2026-05-28 | Sell | 11.48K | $375K | 2026-05-28 | 2026-05-29 |
Fromkin Andrew J. Director · Stock Option (right to buy) · 2026-05-28 | Exercise | 77.18K | $0 | 2026-05-28 | 2026-05-29 |
SEC filings
EDGAR filings in IMVT · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.